2.09  -0.01 (-0.48%)		09-17 16:00
Open: 2.09 High: 2.09 Volume: 2,800,167		Pre. Close: 2.1 Low: 2.09 Market Cap: 105(M)

Short term
Mid term
Targets	6-month :	2.45	1-year :	2.48
Resists	First :	2.09	Second :	2.13
Pivot price	2.09
Supports	First :	2.04	Second :	1.7
MAs	MA(5) :	2.09	MA(20) :	2.09
	MA(100) :	2.01	MA(250) :	1.9
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	45.3	D(3) :	44.5
RSI	RSI(14): 51.2
52-week	High :	2.17	Low :	1.34

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ HLVX ] has closed above bottom band by 39.4%. Bollinger Bands are 83.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 41 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	2.09 - 2.1	2.1 - 2.11
Low:	2.07 - 2.08	2.08 - 2.09
Close:	2.07 - 2.09	2.09 - 2.11

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

Wed, 17 Sep 2025
XOMA Royalty completes acquisition of HilleVax and initiates Nasdaq delisting - Investing.com

Wed, 17 Sep 2025
77.5% Shareholders Accept: XOMA Royalty Acquires Biotech HilleVax in Cash-Plus-CVR Deal Worth $1.95/Share - Stock Titan

Wed, 17 Sep 2025
XOMA Royalty Corporation Completes Tender Offer for HilleVax, Inc. Shares and Merger Finalized - Quiver Quantitative

Wed, 17 Sep 2025
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc. - Yahoo Finance

Tue, 16 Sep 2025
HilleVax, Inc.(NasdaqGS: HLVX) dropped from S&P TMI Index - MarketScreener

Thu, 07 Aug 2025
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of HilleVax, Inc. (NASDAQ: HLVX) - PR Newswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	50 (M)
Shares Float	40 (M)
Held by Insiders	17 (%)
Held by Institutions	70.4 (%)
Shares Short	355 (K)
Shares Short P.Month	444 (K)

EPS	-1.45
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	2.99
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-14.5 %
Return on Equity (ttm)	-40.4 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-1.02
Qtrly Earnings Growth	0 %
Operating Cash Flow	-60 (M)
Levered Free Cash Flow	-31 (M)

PE Ratio	-1.46
PEG Ratio	0
Price to Book value	0.69
Price to Sales	0
Price to Cash Flow	-1.77

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.